Actinium Pharmaceuticals

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ATNM and other ETFs, options, and stocks.

About ATNM

Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of novel targeted therapies known as Antibody Radiation-Conjugates, which combine the targeting ability of antibodies with the cell killing ability of radiation. 

CEO
Sandesh Seth
CEOSandesh Seth
Employees
32
Employees32
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2000
Founded2000
Employees
32
Employees32

ATNM Key Statistics

Market cap
187.63M
Market cap187.63M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
154.12K
Average volume154.12K
High today
$7.50
High today$7.50
Low today
$7.17
Low today$7.17
Open price
$7.30
Open price$7.30
Volume
100.70K
Volume100.70K
52 Week high
$9.68
52 Week high$9.68
52 Week low
$4.41
52 Week low$4.41

ATNM Earnings

-$0.37
-$0.25
-$0.12
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 11, After Hours
ActualExpected Nov 11, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.